Epi One: Funding, Investors & Team (Sep 2026)
We are on a mission to build a revolutionary cancer diagnosis platform to solve the challenge of early cancer prognosis and detection, as well as prediction of post-diagnosis cancer drug response.
Epi One has raised $3.1M across 2 funding rounds on record, the most recent an undisclosed round of $2.1M announced in Dec 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Epi One Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Epi One Funding Rounds
Epi One raised $1.0M in an Angel announced in May 2024.
7 months later, an undisclosed round of $2.1M was announced in Dec 2024.
Epi One Founders and Leadership Team
No contact details are on record for this team yet.
Epi One Funding Compared to Other Biotechnology Startups
Epi One's latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Epi One in Biotechnology and Brooklyn
Companies Similar to Epi One
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Epi One Funding FAQs
What does Epi One do?
We are on a mission to build a revolutionary cancer diagnosis platform to solve the challenge of early cancer prognosis and detection, as well as prediction of post-diagnosis cancer drug response.
How much funding has Epi One raised?
Epi One has raised $3.1M across 2 rounds on record. The most recent is an undisclosed round of $2.1M announced in Dec 2024.
When did Epi One last raise funding?
Epi One's most recent funding round on record is an undisclosed round of $2.1M, announced in Dec 2024.
Who founded Epi One?
FundedIQ lists Sophia F F (Founder) at Epi One.
Where is Epi One headquartered?
Epi One is based in Brooklyn, New York, United States.
How many employees does Epi One have?
Epi One is in the 1-10 employee band.
How does Epi One's funding compare to other Biotechnology startups?
Epi One's latest round of $2.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Epi One Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Epi One is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.